Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy advanced laser-based platform for the treatment ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Patients already treated don’t need to do anything. Boston Scientific has updated its instructions for doctors using catheter technology to treat atrial fibrillation with extreme cooling ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

This article is part of “Dealing the Dead,” a series investigating the use of unclaimed bodies for medical research. In August, a single email triggered a chain of hand-wringing and ...